Login
$MDGL
$440.33 +$2.59 (0.59%) Close

$MDGL 4 SEC Filings

Filed On Filing
11 Sep 2026 Form 4: Sibold William John, Director

Sold 6,362 shares ($3.41M) · Sold 5,221 shares ($2.83M)

20 Aug 2026 Form 4: Kelley Shannon T, General Counsel

Sold 664 shares ($342K)

18 Aug 2026 Form 4: Reed John C, Director

Received 647 shares as a grant or award · Granted 1,078 Stock Option (Right to Buy)

20 Jul 2026 Form 4: Sibold William John, Director

Received 50,000 shares by exercise or conversion · Sold 2,500 shares ($1.37M)

18 Jun 2026 Form 4: Taub Rebecca, Director

Received 454 shares as a grant or award · Granted 766 Stock Option (Right to Buy)

18 Jun 2026 Form 4: Levy Richard S, Director

Received 454 shares as a grant or award · Granted 766 Stock Option (Right to Buy)

18 Jun 2026 Form 4: Fouse Jacqualyn A, Director

Received 454 shares as a grant or award · Granted 766 Stock Option (Right to Buy)

18 Jun 2026 Form 4: Daly James M, Director

Received 454 shares as a grant or award · Granted 766 Stock Option (Right to Buy)

18 Jun 2026 Form 4: Brennan Daniel J., Director

Received 404 shares as a grant or award · Granted 681 Stock Option (Right to Buy)

18 Jun 2026 Form 4: Baker Bros. Advisors Lp, Director and 5 others

Received 1,816 shares as a grant or award · Granted 3,064 Non-Qualified Stock Options (right to buy)

01 Jun 2026 Form 4: Soergel David, Chief Medical Officer

Sold 1,042 shares ($517K)

22 May 2026 Form 4: Levy Richard S, Director

Sold 5,682 shares ($2.93M)

18 May 2026 Form 4: Soergel David, Chief Medical Officer

Sold 844 shares ($435K)

06 Mar 2026 Form 4: Dier Mardi, EVP and CFO

Received 5,215 shares as a grant or award · Granted 6,519 Stock Option (Right to Buy) · Sold 1,982 shares ($854K)

06 Mar 2026 Form 4: Sibold William John, Director

Received 14,995 shares as a grant or award · Granted 18,743 Stock Option (Right to Buy) · Sold 1,663 shares ($718K)

06 Mar 2026 Form 4: Kelley Shannon T, General Counsel

Received 4,017 shares as a grant or award · Granted 5,022 Stock Option (Right to Buy) · Sold 360 shares ($155K)

06 Mar 2026 Form 4: Huntsman Carole, Chief Commercial Officer

Received 3,989 shares as a grant or award · Granted 4,986 Stock Option (Right to Buy) · Sold 419 shares ($181K)

06 Mar 2026 Form 4: Taub Rebecca, Director

Sold 491 shares ($212K)

06 Mar 2026 Form 4: Soergel David, Chief Medical Officer

Received 4,374 shares as a grant or award · Granted 5,467 Stock Option (Right to Buy)

02 Mar 2026 Form 4: Dier Mardi, EVP and CFO

Sold 1,183 shares ($505K)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support